Synthesis, Characterization And

Biological Studies On Symmetrical 2,7-

Disubstituted 9,9’-Dihexylfluorene

Derivatives With Amine And Ether

Bridging Groups by Ishak, Syarmila
SYNTHESIS, CHARACTERIZATION AND 
BIOLOGICAL STUDIES ON SYMMETRICAL 2,7-
DISUBSTITUTED 9,9’-DIHEXYLFLUORENE 
DERIVATIVES WITH AMINE AND ETHER 
BRIDGING GROUPS 
 
 
 
 
 
 
 
SYARMILA BINTI ISHAK 
 
 
 
 
 
 
 
 
 
UNIVERSITI SAINS MALAYSIA 
2019 
SYNTHESIS, CHARACTERIZATION AND 
BIOLOGICAL STUDIES ON SYMMETRICAL 2,7-
DISUBSTITUTED 9,9’-DIHEXYLFLUORENE 
DERIVATIVES WITH AMINE AND ETHER 
BRIDGING GROUPS 
 
 
 
by 
 
 
 
 
SYARMILA BINTI ISHAK 
 
 
 
 
Thesis submitted in fulfillment of the requirements  
for the degree of  
Master of Science 
 
 
 
 
July 2019 
ii 
 
ACKNOWLEDGEMENT 
 
Firstly, I would like to express my sincere gratitude to my main supervisor, 
Prof. Yeap Guan Yeow for his patience, motivation, enthusiasm and continuous 
support throughout my MSc study. His guidance helped me in all the time of 
research and writing of this thesis. I also wish to thank my co-supervisor, Assoc. 
Prof. Dr. Sasidharan Sreenivasan from INFORMM USM for his support and 
technical advice especially on the biological testing. My appreciation also goes to the 
Dean of School of Chemical Sciences for giving me the permission to access to 
research space and facilities available in the school. I am also thankful to the Dean of 
Institute of Postgraduate Studies (IPS) for giving me opportunity to enroll in the MSc 
program at University Sains Malaysia.  
In addition, I would like to express my sincere gratitude to Prof. Dr. Masato 
M. Ito from Soka University for partial support in term of providing some specialty 
chemicals and apparatus required for my research. This appreciation is also dedicated 
to my laboratory mates especially Dr. Arwa Alshargabi, Dr. Faridah Osman, Ms. 
Mursyida Abdul Rahim, Ms. Amanina Juniasari, Ms. Shanmugapriya and Ms. 
Thiagarajan Sangeeta for sharing their knowledge and great assistances in many 
aspects. 
Not forgotten, I wish to thank my beloved husband and family for their great 
support and understanding throughout this journey. 
 
 
iii 
 
TABLE OF CONTENTS 
ACKNOWLEDGEMENT ....................................................................................... ii 
TABLE OF CONTENTS …………………………………………..…………….. iii 
LIST OF TABLES ………………………...…………………………………...… vii 
LIST OF FIGURES ………………………………………………………..……... ix 
LIST OF ABBREVIATION …...…………………………..……….…………..  xiv 
ABSTRAK.…………………………….....…………………………….………... xvii 
ABSTRACT ...…………………………...……………………………………….. xix 
CHAPTER 1: INTRODUCTION & LITERATURE REVIEW ………..……… 1 
1.1 Fluorene ...……………………………………..……………………………. 1 
 1.1.1 Fluorene Derivatives ...………………………………...……………. 4 
1.2 Biological Activities ...……………………………..……………………… 10 
 1.2.1 Cytotoxicity Activity ...………………………………………..…... 10 
 1.2.2 Antioxidant Activity ...……………………………..……………… 13 
 1.2.3 Antimicrobial Activity ...…………………………………...……… 16 
1.3 Problem Statement ...…………………..…………………………………... 21 
1.4 Research Objectives ......………………………………………………….... 22 
1.5 Scope of the Studies ………………...………………………...…………… 22 
 
iv 
 
CHAPTER 2: EXPERIMENTAL…………………………..……….….……….. 24 
2.1 Chemicals………………………...………………………………………… 24 
2.2 Instruments……………………………………...………………………….. 25 
2.3 Cell Line and Culture Condition ……………………...………………...…. 25 
2.4 Test Microorganisms and Growth Media ……….…………………..…….. 26 
2.5 Synthesis………………..……………………………………………….…. 26 
2.5.1 Synthesis of 1,1'-(9,9-dihexyl-9H-fluorene-2,7-diyl)bis(N,N-bis 
(pyridine-2-ylmethyl)methanamine, (FP1) ………....…………...… 26 
2.5.2 Synthesis of 1,1'-(9,9-dihexyl-9H-fluorene-2,7-diyl)bis(N,N-bis 
(benzo[d]thiazol-2-ylmethyl)methanamine, (FT2) …...….………... 27 
2.5.3 Synthesis of 8,8'-(((9,9-dihexyl-9H-fluorene-2,7-diyl)bis 
(methylene))bis(oxy))diquinoline, (FQ3) …...…………………..… 28 
2.6 Characterization…………………………………………………..………... 29 
2.7 Determination of Anticancer Activity .………………………..………...… 30 
 2.7.1 Preparation of Cell Culture ..………..………………………...…… 30 
 2.7.2 MTT Assay ..………………………………………..……………... 30 
2.8 DPPH Radical-scavenging Assay .……………………..………………….. 31 
2.9 Antimicrobial Disc Diffusion Assay ………...…………………………….. 31 
 
v 
 
CHAPTER 3: RESULT AND DISCUSSION…………………...………………. 33 
3.1 1,1'-(9,9-dihexyl-9H-fluorene-2,7-diyl)bis(N,N-bis(pyridin-2-ylmethyl) 
methanamine (FP1) ………………………...……………………...……… 33 
 3.1.1 Physical Characterization ..…………………...……………………. 33 
 3.1.2 Fourier Transform Infrared (FT-IR) Spectroscopy …………...…… 33 
3.1.3 Fourier Transform Nuclear Magnetic Resonance (FT-NMR)  
  Spectroscopy …………………………………………………..…... 36 
3.2 1,1'-(9,9-dihexyl-9H-fluorene-2,7-diyl)bis(N,N-bis(benzo[d]thiazol-2-
ylmethyl)methanamine (FT2) ………...…………………………………… 51 
 3.2.1 Physical Characterization…………………...……………………… 51 
 3.2.2 Fourier Transform Infrared (FT-IR) Spectroscopy .……...………... 51 
 3.2.3 Fourier Transform Nuclear Magnetic Resonance (FT-NMR)   
 Spectroscopy ……………………………………………..………... 54 
3.3 8,8'-(((9,9-dihexyl-9H-fluorene-2,7-diyl)bis(methylene))bis(oxy))-
diquinoline (FQ3) ……….………..……………………………………….. 69 
 3.3.1 Physical Characterization……...…………………………………… 69 
 3.3.2 Fourier Transform Infrared (FT-IR) Spectroscopy..…...…………... 69 
3.3.3  Fourier Transform Nuclear Magnetic Resonance (FT-NMR)   
 Spectroscopy …………………………………………..…………... 72 
3.4 Comparative Fluorescence Properties of Compounds FP1, FT2 & FQ3 .... 87 
vi 
 
3.5 In vitro (Anticancer Screening) Studies of Compounds FP1, FT2 & FQ3.. 89 
3.6 Antioxidant Studies of Compounds FP1, FT2 & FQ3 ...……..…………... 92 
3.7 Antimicrobial Studies of Compounds FP1, FT2 & FQ3 …...………..…… 94 
CHAPTER 4: CONCLUSIONS………..………………………………………... 97 
REFERENCES………………………...………………………………………….. 99 
APPENDICES 
LIST OF PUBLICATION 
RECOMMENDATION FOR FUTURE STUDY 
 
 
 
 
 
 
 
 
 
 
 
 
vii 
 
LIST OF TABLES 
 
Page 
Table 1.1 Common Reactive Oxygen Species (ROS)………………...……… 14 
 
Table 2.1 Chemicals, manufacturer name and the percentage purity (%)…..…24 
 
Table 3.1 Selected FT-IR absorption frequencies (ν/cm-1) and relative  
intensities of FP1 ……..…………………………………………… 34 
 
Table 3.2 1H NMR chemical shifts (δ/ppm) and coupling constant (J/Hz)  
of FP1 ……………………………………………………………... 37 
 
Table 3.3 1H-1H correlations as inferred from COSY experiment for FP1.….. 39 
 
Table 3.4 1H-13C correlations from the 2D HMQC and HMBC experiments  
for FP1………………………………………..…………………..... 47 
 
Table 3.5 Selected FT-IR absorption frequencies (ν/cm-1) and relative  
intensities of FT2……………...……..…………………………….. 52 
 
Table 3.6 1H NMR chemical shifts (δ/ppm) and coupling constant (J/Hz) of  
FT2 ……………………………………………..…………………..55 
 
Table 3.7 1H-1H correlations as deduced from COSY experiment of FT2 ...... 57 
 
Table 3.8 1H-13C correlations from 2D HMQC and HMBC experiments ..….. 65 
 
Table 3.9 Selected FT-IR absorption frequencies (ν/cm-1) and relative 
intensities of FQ3………...……………..……………………...….. 70 
 
 
viii 
 
Table 3.10 1H NMR chemical shifts (δ/ppm) and coupling constant (J/Hz) of  
FQ3 .…...……………...…….………………………………………73 
 
Table 3.11 1H-1H correlations as deduced from COSY experiment for FQ3...... 75 
 
Table 3.12 1H-13C correlations as inferred from the HMQC and HMBC  
experiments for FQ3…………………………………..…………… 83 
 
Table 3.13 IC50 values on the cytotoxicity of the tested compounds against  
HeLa cancer cell line …….……………………………………..…. 91 
 
Table 3.14 Diameter of inhibition zone of FP1, FT2 and FQ3 compounds  
against test microorganisms ………………..…………...………..... 94 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ix 
 
LIST OF FIGURES 
Page 
Figure 1.1 Chemical structure and atomic numbering of fluorene …………...… 1 
 
Figure 1.2 Intramolecular Friedel-Crafts alkylation for the synthesis of  
fluorene ………………………………………………………………2 
 
Figure 1.3 Precedent metal-mediated routes to a fluorene skeleton …………..... 3 
 
Figure 1.4 Fluorene dyes 1-2 with substitution at 9-position and 2,7-position 
demonstrate interaction with DNA …………………………..………5 
 
Figure 1.5 Dibenzofluorene derivatives 3-4 exhibit cytotoxic activity ...…….….6 
 
Figure 1.6 Fluorene derivatives which contains electron donating functional 
moiety substituted at 7-position 5. Fluorene derivative substituted at 
2-position 6 …………………...…...……………………………...… 6 
 
Figure 1.7 Synthetized triazolo[1,3,4]thiadiazole derivative, 6-(4-chlorophenyl) 
-3-(pyridin-4-yl)[1,2,4]triazolo[3,4-b] 7. Synthetized benzimidazole 
hybrid heterocycles 8 ……………………………………….…...….. 8 
 
Figure 1.8 4,6-dimethyl-1l2-pyrazolo[5,4-b]pyridin-3-amine 9, ethyl 2-((3- 
amino-4,6-dimethylpyridin-2-yl)thio)acetate 10 and 2-(phenyl 
(pyridine-2-yl)methylene)hydrazine-1-carbothioamide 11 ..…....….. 9 
 
Figure 1.9 Cyclopenta[b]quinoline-1,8-dione derivatives 12 and 2-Oxo-1,2- 
dihydroquinoline-3-carbaldehyde(4’-methylbenzoyl)hydrazine 13 ... 9 
 
Figure 1.10 Representative examples of antitumor 14 and antioxidant compounds 
15 containing benzothiazole as basic unit ……...……..…………… 10 
 
Figure 1.11 Cisplatin 16 and Mitomycin C (MC) 17 ……..……...…………….. 13 
x 
 
Figure 1.12 Structure of DPPH and reduced DPPH ……………...…………….. 16 
 
Figure 1.13 Evolution of penicillin ……………………………..……………… 18 
 
Figure 1.14 Antibacterial sulfonamide’s common core structure 18. Nalidixic  
acid 19. Nitroheterocyclic. (nitrofurans and metronidazole) 20 ……19 
 
Figure 2.1 Synthetic pathway for the preparation of compounds FP1 ..……… 27 
 
Figure 2.2 Synthetic pathway for the preparation of compounds FT2 …..…….28 
 
Figure 2.3 Synthetic routes toward the formation of FQ3 ……...…………….. 28 
 
Figure 3.1 FT-IR spectrum of 1,1’-(9,9-dihexyl-9H-fluorene-2,7-diyl)bis 
(N,N-bis(pyridine-2-ylmethyl)methanamine, FP1 ………...…...….. 35 
 
Figure 3.2 1H NMR spectrum of 1,1’-(9,9-dihexyl-9H-fluorene-2,7-diyl)bis 
(N,N-bis(pyridine-2-ylmethyl)methanamine, FP1 ………..……….. 40 
 
Figure 3.3 1H-1H COSY spectrum of 1,1’-(9,9-dihexyl-9H-fluorene-2,7-diyl) 
bis(N,N-bis (pyridine-2-ylmethyl)methanamine, FP1 ……….....…. 41 
 
Figure 3.4 Expanded 1H-1H COSY spectrum of 1,1’-(9,9-dihexyl-9H-fluorene- 
2,7-diyl)bis(N,N-bis(pyridine-2-ylmethyl)methanamine, FP1…….. 42 
 
Figure 3.5 13C NMR, DEPT 135 and NMR DEPT 90 spectra of 1,1’-(9,9- 
dihexyl-9H-fluorene-2,7-diyl)bis(N,N-bis(pyridine-2-ylmethyl) 
methanamine, FP1…….…...………………………...………...…... 44 
 
Figure 3.6 1H-13C HMQC spectrum of 1,1’-(9,9-dihexyl-9H-fluorene-2,7-diyl) 
bis(N,N-bis(pyridine-2-ylmethyl)methanamine, FP1…...….…..….. 48 
 
Figure 3.7 1H-13C HMBC spectrum of 1,1’-(9,9-dihexyl-9H-fluorene-2,7-diyl) 
bis(N,N-bis(pyridine-2-ylmethyl)methanamine, FP1 ………......…. 49 
xi 
 
Figure 3.8 Expanded 1H-13C HMBC spectrum of 1,1’-(9,9-dihexyl-9H- 
fluorene-2,7-diyl)bis(N,N-bis(pyridine-2-ylmethyl)methanamine, 
FP1......................................................................................................50 
 
Figure 3.9 FT-IR spectrum of 1,1'-(9,9-dihexyl-9H-fluorene-2,7-diyl)bis(N,N- 
bis(benzo[d]thiazol-2-ylmethyl)methanamine, FT2……………...... 53 
 
Figure 3.10 1H NMR spectrum of 1,1'-(9,9-dihexyl-9H-fluorene-2,7-diyl)bis 
(N,N-bis(benzo[d]thiazol-2-ylmethyl)methanamine, FT2 …..…….. 58 
 
Figure 3.11 1H-1H COSY spectrum of 1,1'-(9,9-dihexyl-9H-fluorene-2,7- 
diyl)bis(N,N-bis(benzo[d]thiazol-2-ylmethyl)methanamine, FT2 ... 59 
 
Figure 3.12 Expanded 1H-1H COSY spectrum of 1,1'-(9,9-dihexyl-9H-fluorene- 
2,7-diyl)bis(N,N-bis(benzo[d]thiazol-2-ylmethyl)methanamine, 
FT2……………………………………………………………….... 60 
 
Figure 3.13 13C NMR, DEPT 135 and DEPT 90 spectra of 1,1'-(9,9-dihexyl- 
9H-fluorene-2,7-diyl)bis(N,N-bis(benzo[d]thiazol-2-ylmethyl) 
methanamine, FT2…….……...………………………...………….. 62 
 
Figure 3.14 1H-13C HMQC spectrum of 1,1'-(9,9-dihexyl-9H-fluorene-2,7- 
diyl)bis(N,N-bis(benzo[d]thiazol-2-ylmethyl)methanamine, FT2… 66 
 
Figure 3.15 1H-13C HMBC spectrum of 1,1'-(9,9-dihexyl-9H-fluorene-2,7-diyl) 
 bis(N,N-bis(benzo[d]thiazol-2-ylmethyl)methanamine, FT2 ….…..67 
 
Figure 3.16 Expanded 1H-13C HMBC spectrum of 1,1'-(9,9-dihexyl-9H- 
fluorene-2,7-diyl)bis(N,N-bis(benzo[d]thiazol-2-ylmethyl) 
methanamine, FT2….……………………………………………… 68 
 
Figure 3.17 FT-IR spectrum of 8,8'-(((9,9-dihexyl-9H-fluorene-2,7-diyl)bis 
(methylene))bis(oxy))diquinoline, FQ3……………..…………….. 71 
 
xii 
 
Figure 3.18 1H NMR spectrum of 8,8'-(((9,9-dihexyl-9H-fluorene-2,7-diyl)bis 
(methylene))bis(oxy))diquinoline, FQ3………………………..….. 76 
 
Figure 3.19 1H-1H COSY spectrum of  8,8'-(((9,9-dihexyl-9H-fluorene-2,7- 
diyl)bis(methylene))bis(oxy))diquinoline, FQ3……..…………….. 77 
 
Figure 3.20 Expanded 1H-1H COSY spectrum of  8,8'-(((9,9-dihexyl-9H- 
fluorene-2,7-diyl)bis(methylene))bis(oxy))diquinoline, FQ3….….. 78 
 
Figure 3.21 13C NMR, DEPT 135 and DEPT 90 spectra of 8,8'-(((9,9-dihexyl- 
9H-fluorene-2,7-diyl)bis(methylene))bis(oxy))diquinoline, FQ3..... 80 
 
Figure 3.22 1H-13C HMQC spectrum of 8,8'-(((9,9-dihexyl-9H-fluorene-2,7- 
diyl)bis(methylene))bis(oxy))diquinoline, FQ3 ……………..……. 84 
 
Figure 3.23 1H-13C HMBC spectrum of 8,8'-(((9,9-dihexyl-9H-fluorene-2,7- 
diyl)bis(methylene))bis(oxy))diquinoline, FQ3…………..…….......85 
 
Figure 3.24 Expanded 1H-13C HMBC spectrum of  8,8'-(((9,9-dihexyl- 
9H-fluorene-2,7-diyl)bis(methylene))bis(oxy))diquinoline, FQ3…. 86 
 
Figure 3.25 UV-Vis absorption spectra of FP1, FT2 and FQ3……..….………. 87 
 
Figure 3.26 Fluorescence spectra of compounds FP1, FT2 and FQ3………..… 88 
 
Figure 3.27 Cell viability of HeLa cells treated with compounds FP1, FT2 and  
FQ3 with 5-fluorouracil (positive control) and DMSO (negative  
control) by using MTT assay……………………..………………....90 
 
Figure 3.28 DPPH radical scavenging activities of compounds FP1, FT2 and  
 FQ3………………………………..……………………………...…92 
 
 
xiii 
 
Figure 3.29 Representative examples of the title compounds treated against  
tested microorganisms……………..………..……………...……….95 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xiv 
 
LIST OF ABBREVIATIONS 
 
%  Percentage 
µgmL-1 Microgram per Milliliter 
13C NMR Carbon Nuclear Magnetic Resonance 
1H NMR Proton Nuclear Magnetic Resonance 
CDCL3 Deuterated Chloroform 
CFU  Colony Forming Units 
CO2  Carbon Dioxide 
COSY  Correlation Spectroscopy 
d  Doublet 
DEPT   Distortionless Enhancement by Polarization Transfer 
DMEM Dulbecco's Modified Eagle Medium 
DMSO  Dimethyl Sulfoxide 
DNA  Deoxyribonucleic Acid 
DPPH  2, 2-Diphenyl-1- picrylhydrazyl 
EDG  Electron Donating Group 
EWG  Electron Withdrawing Group 
FBS  Fetal Bovine Serum  
FDA  Food and Drugs Administration 
FT-IR  Fourier-Transform Infrared 
FT-NMR Fourier Transform Nuclear Magnetic Resonance 
HEK293 Human Embryonic Kidney 293 
HeLa  Human Epithelial Carcinoma Cell Line 
HMBC Heteronuclar Multiple Bond Correlation 
xv 
 
HMQC Heteronuclear Multiple Quantum Correlation 
HT-29  Human Colorectal Adenocarcinoma Cell Line 
Hz  Hertz 
IC50  The Half Maximal Inhibitory Concentration 
J  Coupling Constant 
K2CO3  Potassium Carbonate 
KI  Potassium Iodide 
kPa  Kilopascal 
M  Molar 
m  Multiplet 
MCF-7 Michigan Cancer Foundation-7 (breast adenocarcinoma cells) 
MHA  Mueller-Hinton Agar 
MHz  Megahertz 
MTT  3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide 
NCI  National Cancer Institute 
nm  Nanometer 
ºC  Degree Celcius 
PBS  Phosphate Buffered Saline 
ppm  Part per million 
q   Quartet 
RNS  Reactive Nitrogen Species  
ROS  Reactive Oxygen Species  
s  Singlet 
SDA  Sbouraud Dextrose Agar  
t   Triplet 
xvi 
 
UV  Ultraviolet 
Vero  Verda Rino (Green African monkey kidney cells) 
WHO  The World Health Organization 
δ   Chemical Shift 
λ  Lambda (wavelength) 
π   Pi  
σ  Sigma 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xvii 
 
SINTESIS, PENCIRIAN DAN KAJIAN BIOLOGI PADA TERBITAN 
SIMETRI 2,7-DIPENUKARGANTIAN 9,9’-DIIHEKSILFLUORENA YANG 
MENGANDUNGI KUMPULAN TITIAN AMINA DAN ETER 
 
ABSTRAK 
 
Tiga terbitan fluorena baru yang dinamakan 1,1’-(9,9-diheksil-9H-fluorena-
2,7-diyl)bis(N,N-bis(piridina-2-metil)metanmina (FP1), 1,1'-(9,9-diheksil-9H-
fluorena-2,7-diyl)bis(N,N-bis(benzo[d]thiazol-2-metil)metanmina (FT2) dan 8,8'-
(((9,9-diheksil-9H-fluorena-2,7-diyl)bis(metilena))bis(oxi))diquinolina (FQ3) telah 
berjaya disintesis dengan hasil yang memuaskan iaitu 60 %, 66 % dan 63 %, masing-
masing. Struktur molekul bagi kesemua sebatian yang disintesis telah dijelaskan 
melalui spektroskopi FT-IR, 1H NMR, 13C NMR, DEPT, 1H-1H COSY, 1H-13C 
HMQC, 1H-13C HMBC. Ciri pendarfluor bagi kesemua sebatian telah dikaji melalui 
UV-Vis dan spektroskopi pendarfluor. Kajian biologi termasuk aktiviti in-vitro 
sitotoksik, antimikrob dan antioksidan bagi kesemua sebatian telah disiasat. Aktiviti 
in-vitro sitotoksik bagi kesemua sebatian telah diuji terhadap sel kanser serviks 
manusia (HeLa), dengan menggunakan 5-fluororacil sebagai ubat standad (IC50 = 
27.82 µg/mL). FP1 menunjukkan aktiviti sitotoksik dengan menghasilkan nilai IC50 
bersamaan 28.58 ± 0.05 µg/mL manakala FT2 dan FQ3 menunjukkan tiada aktiviti 
untuk sel kanser HeLa dengan nilai IC50 didapati bersamaan 141.13 ± 0.03 µg/mL 
dan 223.81 ± 0.02 µg/mL, masing-masing. Aktiviti antioksidan ditunjukkan melalui 
aktiviti penangkap radikal DPPH dimana kesemua sebatian didapati mempamerkan 
aktiviti antioksidan yang rendah. Sementara itu, kajian aktiviti antimikrob bagi 
kesemua sebatian yang disintesis dikendalikan melalui kaedah penyerapan disk yang 
xviii 
 
dijalankan ke atas Staphylococcus aureus, Bacillus subtilis, Escherichia coli, 
Candida albicans dan Saccharomyces cerevisiae. Kloramfenikol digunakan sebagai 
kawalan positif dan zon perencatan direkodkan dalam milimeter. FP1 dan FT2 
didapati menunjukkan aktiviti antimikrob yang baik terhadap semua mikroorganisma 
yang diuji manakala FQ3 menunjukkan tiada aktiviti kecuali pada kepekatan 10 
mg/mL, dimana ia menunjukkan aktiviti sederhana ke atas yis Saccharomyces 
cerevisiae.  
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SYNTHESIS, CHARACTERIZATION AND BIOLOGICAL STUDIES ON 
SYMMETRICAL 2,7-DISUBSTITUTED 9,9’-DIHEXYLFLUORENE 
DERIVATIVES WITH AMINE AND ETHER BRIDGING GROUPS 
 
ABSTRACT 
 
Three new fluorene derivatives namely, 1,1’-(9,9-dihexyl-9H-fluorene-2,7-
diyl)bis(N,N-bis(pyridine-2-ylmethyl)methanamine (FP1), 1,1'-(9,9-dihexyl-9H-
fluorene-2,7-diyl)bis(N,N-bis(benzo[d]thiazol-2-ylmethyl)methanamine (FT2) and 
8,8'-(((9,9-dihexyl-9H-fluorene-2,7-diyl)bis(methylene))bis(oxy))diquinoline (FQ3) 
have been successfully synthesized in moderate yield 60 %, 66 % and 63 %, 
respectively. The molecular structure of all the synthesized compounds were 
elucidated via FT-IR, 1H NMR, 13C NMR, DEPT, 1H-1H COSY, 1H-13C HMQC, 1H-
13C HMBC spectroscopy. Fluorescence properties of all the final compounds were 
examined by UV-Vis and fluorescence. Biological studies including in-vitro 
cytotoxicity, antimicrobial and antioxidant activities of the title compounds were 
investigated. The in-vitro cytotoxic activity of the title compounds was evaluated 
against human cervical (HeLa) cancer cell line, with 5-fluororacil used as standard 
drug (IC50 = 27.82 µg/mL). FP1 demonstrated cytotoxic activity with IC50 value 
28.58 ± 0.05 µg/mL while FT2 and FQ3 showed no activity for HeLa cell as the IC50 
values were determined to be 141.13 ± 0.03 µg/mL and 223.81 ± 0.02 µg/mL, 
respectively. Antioxidant activity of the target compounds was demonstrated by 
DPPH radical scavenging activity where the title compounds were found to exhibit 
very low scavenging activity. Meanwhile, Antimicrobial test of all the title 
compounds was conducted by disc diffusion assay performed on Staphylococcus 
xx 
 
aureus, Bacillus subtilis, Escherichia coli, Candida albicans and Saccharomyces 
cerevisiae. Chloramphenicol was used as positive control and the inhibitory zones 
were recorded in millimeters. FP1 and FT2 were found to have good antimicrobial 
activity against the tested microorganisms while FQ3 showed no activity except for 
concentration at 10 mg/mL, where it shows moderate activity on the yeast 
Saccharomyces cerevisiae.  
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CHAPTER 1 
INTRODUCTION 
1.1 Fluorene 
The hydrocarbon fluorene has been known for more than seven decades. It 
was first discovered by a French chemist, Marcellin Berthelot when he carried out a 
research on the pyrogenetic hydrocarbons at the College de France in 1867 
(Rieveschl and Ray, 1938). Fluorene was isolated from anthracene oil fraction of 
coal tar which boiled between 270 ºC and 310 °C (Hartnell, 1979). It was then 
recrystallized from boiling alcohol to afford white fluorescent laminae which melted 
at 113 °C. Berthelot was impressed by its beautiful fluorescence and named it as 
“Fluorene”. Its odor was described as being “insipid, sweetish, and at the same time 
distressing to breathe”. In the early of 20th century, the amount of investigation on 
fluorene remains quite scanty as compared to other hydrocarbons such as anthracene 
or phenanthrene. 
Fluorene (C13H10) is a polycyclic aromatic hydrocarbon that has three rings 
covalently bonded together (Figure 1.1). The term 'polycyclic' refers to the multiple 
rings involved, 'aromatic' denotes the presence of benzene rings, and 'hydrocarbon' 
shows that the molecule contains only carbon and hydrogen atoms.  
 
Figure 1.1 Chemical structure and atomic numbering of fluorene. 
2 
 
Since seven decades ago, a considerable amount of studies on fluorene had been 
carried out by X-ray crystallography. The planarity of the molecule is the most 
significant point of difference in the structure analyzed. The molecule is of interest 
from a biological point of view because of its relation to the carcinogenic 
dibenzofluorenes, and it is crucial to know whether these compounds have planar 
molecules similar to the carcinogenic compounds based on 1,2-benzanthracene. The 
first X-ray crystal structure investigation of fluorene was reported by Hengstenberg 
et al. in I929, followed by other researchers in the following years before it arrived at 
the conclusion that the molecule is planar (Burns and Iball, 1955). The methylene 
bridge in the fluorene enhanced the planarity of the two phenyl rings. As such, it 
increased the overlap of the orbitals and the degree of conjugation of the aromatic 
system (Abbel, 2008). Hence, fluorene absorbs at longer wavelengths than other 
compounds with closely related structure. 
The classical method for the synthesis of fluorene is intramolecular 
Friedel−Crafts alkylation (Figure 1.2) promoted by Brønsted or Lewis acids (Xu et 
al., 2015). Friedel–Crafts alkylations are among the most powerful C–C bond-
forming processes for the synthesis of functionalized aromatic compounds (Sarkar et 
al., 2012). Intramolecular reactions normally occur much more easily as compared to 
intermolecular reaction.   
 
Figure 1.2 Intramolecular Friedel-Crafts alkylation for the synthesis of fluorene. 
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In recent years, transition-metal-mediated cyclization for the synthesis of 
fluorene (Figure 1.3) have been extensively investigated as a promising route 
utilizing a C-H bond activation strategy (Liu et al., 2010; Morimoto et al., 2012; 
Hwang et al., 2009). It is apparent that the key to accessing fluorene derivatives is 
the construction of carbon−carbon bonds. The cleavage of carbon-carbon σ-bonds by 
transition-metal complexes and their use for chemical transformation would provide 
a conceptually new strategy in organic synthesis. 
 
Figure 1.3 Precedent metal-mediated routes to a fluorene skeleton. (Campeau et al., 
2006; Fuchibe and Akiyama, 2006; Tobisu et al., 2008; Dong and Hu, 2006) 
However, previous studies had shown that some of these methods have many 
limitations and disadvantages including the reactions were inclined to backward, 
non-availability of the substrates, drastic reaction conditions, uses of toxic and 
expensive chemicals as well as production of large amounts of waste, which limit 
their applications in industry. Therefore, the simple, straightforward, high yielding, 
practical, and environmentally friendly method for the synthesis of substituted 
fluorene derivatives are still in high demand and continuously developed by many 
researchers.  
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1.1.1 Fluorene Derivatives 
An extensive research on fluorene to explore its 
potential applications in various areas had been carried out. The alteration or 
introduction of some fragments to the fluorene may result in enhancing its 
application in different areas. Fluorene derivatives received a huge attention due to 
their luminescent and electroluminescent properties, caused by the inter- and 
intramolecular charge distribution. In the industrial sector, fluorene could be a good 
candidate for blue light-emitting and hole-transporting materials, ‘naked eye’ sensors 
for sensing various metal ions and as efficient multifunctional chemosensor-filtering 
devices (Li et al., 2004; Hung et al., 2016). Besides, fluorene had also been regarded 
as potential candidate for semiconducting applications as well as essential agent in 
solar cells (Hayashi et al., 2009; Chandrasekharam et al., 2011). A simple, low-cost 
and efficient fine chemical is among the important criteria needed for industrial use. 
On the other hand, the development of the production in drugs and pharmaceuticals 
has brought the fluorene compound to the vast attention of the researchers from all 
over the world. This can be exemplified through the testing of fluorene compounds 
with various alteration and substitution that showed numerous biological applications 
such as interaction of DNA with fluorene, antibacterial, anticancer and 
antiproliferative.   
Although fluorene contains benzene rings which are known to be highly 
carcinogenic to human, but many established drugs for the treatment of various 
diseases are prepared from benzene-containing compounds. Many reports had 
claimed that alteration of the structure of polycyclic aromatic hydrocarbons could 
mitigate their deleterious effects, emphasizing their interaction with specific cell 
organelles to evoke specific cytotoxic reactions (Banik et al., 2010). As the result, 
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many fluorene, carbazoles, anthracenes, and related structures are in current clinical 
use.  
Figure 1.4 Fluorene dyes 1-2 with substitution at 9-position and 2,7-position 
demonstrate interaction with DNA. (Przonska et al., 2004) 
Facile modification of fluorene at the 9-position allows for the introduction of alkyl 
moiety or other functional groups into the fluorene as well as to induce steric 
hindrance which helps in improving its optical characteristic (Goodman et al., 2005; 
Sannasi et al., 2015). Studies on fluorene dyes 1-2 in Figure 1.4 as conducted by 
Przonska et al. with the substitution at 9-position and 2,7-position showed the 
breakage of the helix structure of both normal and tumor DNAs as well as the partial 
denaturation with the luminescence evidence upon injection of the dyes.  
Studies of some fluorene derivatives with various substitution positions that 
exhibit positive cytotoxic activities had well been reported. In 2009, Banik et al. 
synthesized a 4-carbon side chain with a heterocyclic base at the end of the aromatic 
ring in fluorene through nitrogen (Figure 1.5) and evaluation of its cytotoxicity 
against a number of tumor cell lines. Besides, Marinova et al. has reported the 
studies on the synthesis, cytotoxicity and other biological tests of fluorene derivative 
wherein the cell viability decreased significantly after being treated with the 
compounds (Marinova et al., 2013; Marinova et al., 2016). This observation 
indicated that the compounds could behave as potential anticancer agents. 
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Figure 1.5 Dibenzofluorene derivatives exhibit cytotoxic activity. 
Beside cytotoxic activity, antimicrobial and antioxidant activities are among 
the preferred biological tests of fluorene compounds. Ahmad et al. synthesized some 
heterocyclic fluorene compounds derived from Schiff base (Figure 1.6 5) and 
evaluated their activity in vitro growth inhibitory against a standard strain of 
pathogenic microorganism including Gram–positive bacteria and Gram-negative 
bacteria. The result showed that the studied compounds effectively inhibit the growth 
of bacteria (Ahmad et al., 2015). The research on fluorene derivatives that had been 
conducted by Yorur-Gorecy et al. and Thirunarayanan in 2016 and 2017, 
respectively, showed good free radical scavenging activity (Figure 1.6 6) by 
inhibiting DPPH radical in a concentration-dependent manner (Yorur-Goreci et al., 
2016; Thirunarayanan, 2017). 
 
Figure 1.6 Fluorene derivatives which contains electron donating functional moiety 
substituted at 7-position 5. Fluorene derivative substituted at 2-position 6. 
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Compounds introduced to fluorene also played an important role in 
enhancing the effectiveness of the fluorene derivatives toward its biological 
properties. Heterocyclic compounds itself have always been on the forefront of 
attention because of their numerous uses in pharmaceutical applications (Kaur, 
2015). Typical hetero atoms include nitrogen, oxygen, and sulfur. Nitrogen, oxygen 
and sulfur-containing heterocycles have a special interest because they constitute an 
important class of natural and non-natural products, many of which exhibit useful 
biological activities. However, nitrogen-containing heterocycle is the most preferable 
and its unique structures had led to several applications in different areas (Sondhi et 
al., 2005; Bhuiyan et al., 2006). Besides, small-ring nitrogen and sulfur-containing 
heterocycles (Figure 1.7) had also been investigated for a long time owing to their 
synthetic diversity and therapeutic relevance. Structure 7 in Figure 1.7 displays the 
chemical representation of synthesized nitrogen heterocycle with proven 
antiproliferative activity, with superior selectivity for gastric cancer cell lines whilst 
structure 8 in Figure 1.7 shows chemical representation of synthesized benzimidazole 
hybrid heterocycles with superior selectivity for leukemia cell lines. Food and Drugs 
Administration (FDA) databases had revealed the structural significance of nitrogen-
based and sulfur-based heterocyclic compounds in the drug design and engineering 
of pharmaceuticals with nearly 60% of unique small-molecule drugs containing a 
nitrogen heterocycle (Martins, 2015).  
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Figure 1.7 Synthetized triazolo[1,3,4]thiadiazole derivative, 6-(4-chlorophenyl)-3-
(pyridin-4-yl)[1,2,4]triazolo[3,4-b] 7 (Kamel and Abdo, 2014). Synthetized 
benzimidazole hybrid heterocycles 8 (Husain et al., 2013). 
Among all the heterocycles, pyridine, thiazole and quinoline have attracted 
interest as these heterocycles possess tremendous applications in medicinal field. 
Pyridine is a basic heterocyclic organic compound with the chemical formula C5H5N 
and has a conjugated system of six π-electrons resembling benzene, that are 
delocalized over the heterocyclic ring. Nitrogen-containing six-membered aromatic 
pyridine and its derivatives (Figure 1.8) play a vital role in the field of heterocyclic 
chemistry and at the same time are claimed to be widely used for many applications 
in medicinal science such as anticancer, antimicrobial and antidiabetic (Altaf et al., 
2015). Similar to the pyridine, quinoline is also a nitrogen-based heterocycle that 
received a broad attention from researchers in different field of studies (Figure 1.9). 
The ring system of quinoline exists in alkaloids, therapeutics and synthetic analogues 
with exciting biological activities such as anticancer, anti-bacterial as well as 
antioxidant activities (Miri et al., 2011; Marella et al., 2013; Orhan Puskullu et al., 
2013). 
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Figure 1.8 4,6-dimethyl-1l2-pyrazolo[5,4-b]pyridin-3-amine 9, ethyl 2-((3-amino-
4,6-dimethylpyridin-2-yl)thio)acetate 10 and 2-(phenyl(pyridin-2-yl)methylene) 
hydrazine1-carbothioamide 11. 
 
Figure 1.9 Cyclopenta[b]quinoline-1,8-dione derivatives 12. 2-Oxo-1,2-dihydro 
quinoline-3-carbaldehyde (4’-methylbenzoyl) hydrazine 13.  
On the other hand, benzothiazole is a heterocycle containing both nitrogen and 
sulfur. It has been identified to play an important role in medical chemistry. Its 
derivatives are associated with a wide range of biological properties such as 
antimicrobial, antimalarial, anticancer, hypertension as well as in the application 
related to the drug development for the treatment of allergies (Figure 1.10) (Cabrera-
Pérez et al., 2016; Sharma et al., 2013). 
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Figure 1.10 Representative examples of antitumor 14 and antioxidant compounds 15 
containing benzothiazole as basic unit. 
In view of the importance of fluorene and heterocyclic compounds primarily 
in biological applications such as anticancer, antimicrobial and antioxidant, the 
synthesis and engineering on the new compounds of 9,9’-dihexylfluorene with 
heterocyclic substituents at 2,7-substituted position has continued to be explored by 
the researchers.  
1.2 Biological Activities 
1.2.1 Cytotoxicity Activity 
Cytotoxicity test is one of the biological screening tests that uses tissue cells 
in vitro to observe the cell growth, reproduction and morphological effects by 
medical devices (Li et al., 2015). Cytotoxic is defined as toxic or detrimental to cells. 
The prefix cyto- connotes a cell, origins from the Greek word kytos meaning hollow, 
as a cell or container. Toxic is from the Greek toxikon which means poison. Besides 
in vivo, in vitro test is the alternative method into non-clinical safety testing that 
economize time and costs, as well as to protect animals. Currently, animal tests are 
mandatory for the evaluation of acute toxicity of chemicals and new drugs. The 
replacement of in vivo test by alternative in vitro assays would offer the opportunity 
to screen and access numerous compounds or extracts at the same time, to predict 
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acute oral toxicity and thus increase drug development processes as well as to show a 
proactive pursuit of ethical and animal welfare issues. 
Cancer is a life threatening disease and remains a tremendous health problem 
all over the world. According to The World Health Organization (WHO), it is 
estimated that there were 7.6 million deaths due to cancer in 2008 and this number is 
likely to rise to 13.1 million deaths by the year 2030 (Farooqui et al., 2013). Cervical 
cancer has been reported as one of the common cancers that could lead to the death 
of Malaysian female cancer patients and the number of cervical cancer is increasing 
gradually (Othman et al., 2009). Cancer cells differ from normal cells in many ways 
that allow them to grow out of control and become invasive. The significant 
difference is that cancer cells are less specialized than normal cells. Normal cells 
mature into very distinct cell types with specific functions while cancer cells do not. 
In addition, cancer cells are able to ignore signals that normally tell cells to stop 
dividing or that begin a process known as programmed cell death, or apoptosis, 
which the body uses to get rid of unneeded cells. To be specific, apoptosis is a 
process by which cells are systematically destroyed and removed without elicits 
inflammatory response. Cells undergo orderly typical morphological changes such as 
membrane blebbing, shrinkage, chromatin condensation and phagocytosis of 
apoptosis bodies (Manahan, 2002). Cancer drugs act upon rapidly dividing cancer 
cells and destroy them. There are many kinds of anticancer drugs discovered such as 
alkylating agents, anti-metabolites, anti-microtubule agents, topoisomerase inhibitors 
and cytotoxic agents (Swift and Golsteyn, 2014; Mihlon et al., 2010). 
In vitro cytotoxicity screenings provide important preliminary data to confirm 
compounds synthesized with potential anticancer properties (Ping, 2014). The IC50 
value shows the inhibition concentration at which only 50% of the cells are viable. 
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The parameters measured were according to the National Cancer Institute (NCI) 
guidelines in which IC50< 30 µgmL-1 is considered active (Aini et al., 2008). Cell-
based assays using established cell lines are commonly employed in which the toxic 
effects of compounds can be evaluated. Some of the common cell lines used in the 
cytotoxicity study including Vero (green African monkey kidney cells), MCF-7 
(breast adenocarcinoma cells), HT-29 (colon adenocarcinoma cells), HEK293 
(human embryonic kidney-derived epithelial cells) and HeLa (cervical 
adenocarcinoma cells). In this study, HeLa was chosen as cell lines for in vitro 
cytotoxicity screening of all compounds synthesized. HeLa cells were the first line of 
human cells to survive in vitro (in a test tube) grown by a researcher named Dr. 
George Gey in 1951 (Lucey et al., 2009). After more than 50 years, there are now 
billions of HeLa cells in laboratories all over the world. It's the most commonly used 
cell line known to be extremely resilient.  
The development of potent and effective novel antineoplastic drugs is one of 
the most intensely persuaded goals of contemporary medicinal chemistry. The 
discovery of new synthetic compounds shows the importance of an extensive 
cooperation between industry and cancer institute (Schwartsmann et al.,1988). 
Synthetic compounds are usually obtained from pharmaceutical industries and 
academic institutions. Cisplatin, or cis-diamminedichloroplatinum(II) (Figure 1.11 
16), that serve as alkylating agent, is one of the examples of a successful synthesized 
compound widely used as anticancer drugs. It is one of the most active anticancer 
agents that have ever been introduced for clinical use (Ellahioui et al., 2017). Most of 
the anticancer drugs that serve as alkylating agent are simple in structure. Smaller 
molecule makes it easier to bind with the double helix of DNA. For cytotoxic drug, 
mitomycin C (Figure 1.11 17) is among the examples of commercial cytotoxic drugs 
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classes available in market. Mitomycin C drugs act upon rapidly dividing cancer 
cells by selectively inhibit the synthesis of deoxyribonucleic acid (DNA). 
 
Figure 1.11 Cisplatin 16 and Mitomycin C (MC) 17. 
However, the effectiveness of many existing cytotoxic drugs, sometimes 
known as antineoplastic drugs is limited by their toxicity to normal rapidly growing 
cells or limited by the identification of unique biochemical aspects of malignancies 
that could be exploited to selectively target tumor cells. It has been reported that over 
600,000 compounds screened with cytotoxicity by then, less than 40 agents were 
routinely used in the clinic (Ajit, 2009). Compounds synthesized must be selectively 
toxic on cancer cells, which mean toxic to cancer cells but non-toxic to normal cells. 
1.2.2 Antioxidant Activity 
 Antioxidants are substances or chemicals that interact with and neutralize free 
radicals, thus preventing them from causing damage to cells. Free radical is an atom 
or molecule that bears an unpaired electron and is extremely reactive, capable of 
engaging in rapid change reaction that destabilize other molecules and generate many 
more free radicals. Having an unpaired electron makes the molecule highly unstable 
and in order to become more stable, free radicals attack other molecule to form pairs 
with other electron and left that molecule as free radicals. Excessive free radicals 
such as reactive oxygen species (ROS) and reactive nitrogen species (RNS) may be 
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harmful as they can initiate biomolecular oxidations which lead to cell injury and 
death, and create oxidative stress (Chew and Lim, 2018). As the result, it will lead to 
numerous diseases and disorders such as cancer, aging, arteriosclerosis and arthritis. 
Some free radicals are generated in the human body when oxidation occurs during 
aerobic respiration while some other free radicals are derived from external sources 
such as tobacco smoke, ultra-violet light, ionizing radiation and environmental 
pollutants.  
ROS is a type of free radicals that contain the oxygen element. It is the most 
common type of free radicals produced in living tissue. Examples of ROS include 
superoxide (O2•-), peroxyl (ROO•), hydrogen peroxide (H2O2), alkoxyl (RO•) and 
hydroxyl ion (OH-). ROS are the contributors of oxidative stress when present at 
high level of concentration in which it become toxic and disrupt the antioxidant 
defense system of the body as well as oxidize nucleic acids, proteins, lipids or DNA 
that result in initiating degenerative diseases (Darkwah et al., 2018). The increased 
production of ROS is considered a universal feature of stress conditions where 
oxidative stress can be defined as “state in which oxidation exceeds the antioxidant 
systems in the body secondary to a loss of the balance between them” (Yoshikawa 
and Naito, 2002). Examples of some ROS are listed in Table 1.1 below. 
 
Table 1.1 Common Reactive Oxygen Species (ROS) 
HO2•  
CO3• 
HOBr 
ONOO- 
NO• 
CIO- 
Hydroperoxyl 
Carbonate 
Hypobromous acid 
Peroxynitrite 
Nitric oxide 
Hypochlorite ion 
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Antioxidants are the main defense mechanism in the body acting as free 
radical scavengers. Antioxidants can be grouped into three classes depending on its 
abilities in human body (Mehta and Gowder, 2015). The first class of antioxidants is 
the work done by the enzymes to control initial free radical production. For example, 
superoxide, hydrogen peroxide, and hydroxyl radicals are formed upon aerobic 
respiration. Enzymes such as catalase, dismutase and glutathione peroxidases will 
take action on those radicals either to decrease their formation or to remove them. 
These enzymes require metal cofactor to function. Secondly, we need antioxidants 
intake as the antioxidants produced naturally by the body are inadequate to neutralize 
all of the free radicals in the body. These antioxidants intake are important in human 
body as they are capable of ending the chain reaction of free radicals through proton 
donation. The third class of antioxidant is replenishers. The source of protons comes 
from structures that can readily donate a proton while remaining stable so as not to 
become a free radical. Examples of replenishers include carotenoids, flavonoids 
coenzyme Q and glutathione.  
In this study, antioxidant test of all the synthesized compounds were 
conducted by DPPH scavenging activity method. This method was introduced in 
1958 by Marsden Blois who was working at Stanford University. DPPH scavenging 
method become popular in antioxidant studies as it is a rapid, simple, highly sensitive 
and inexpensive method to measure antioxidant capacity by using the free radical, 
2,2-Diphenyl-1- picrylhydrazyl (DPPH) (Shekhar and Anju, 2014). Figure 1.12 
below shows DPPH upon accepting electron from antioxidant and reduced to a stable 
molecule. DPPH is a purple chromagen stable free radical that accepts an electron or 
hydrogen radical to become a stable diamagnetic molecule. DPPH scavenging 
activity assay is based on the theory that a hydrogen donor is an antioxidant. In this 
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assay, DPPH is reduced by antioxidant/reducing compounds to the corresponding 
pale yellow hydrazine (Boligon et al., 2014). The free radical DPPH with an odd 
electron gives a maximum absorption at 517 nm (purple colour). The purple colour 
turns to yellow followed by the formation of DPPH upon absorption of hydrogen 
from an antioxidant. This reaction is stoichiometric with respect to the number of 
hydrogen atoms absorbed. Therefore, the antioxidant effect can be easily evaluated 
by following the decrease of UV absorption at 517 nm. 
 
 
Figure 1.12 Structure of DPPH and reduced DPPH. 
 
1.2.3 Antimicrobial Activity 
 Antimicrobial can be defined as any substance of natural, synthetic or 
semisynthetic that kills or inhibits the growth of microorganisms but causes little or 
no damage to the host. The history of antimicrobial discoveries improved before the 
20th century.  Louis Pasteur, a French chemist and microbiologist, proved the “Germ 
Theory”, which proposed that certain diseases are caused by specific microbes 
(Pouyan, 2014). This theory was suggested long before the discovery of bacteria, but 
did not receive general acceptance. In 1864, Pasteur demonstrated that 
microorganisms arise from living “germs” rather than from nonliving matter. From 
the studies, Pasteur made a conclusion that there are a great variety of 
microorganisms, each capable of reproducing its own kind. According to this theory, 
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different diseases are caused by different type of microorganisms. In other words, 
microorganisms are responsible for a variety of infectious diseases that had been 
afflicting mankind from ancient days. 
One of the important medical treatments is antimicrobial chemotherapy. A 
German scientist named Paul Ehrlich was the first to investigate antibacterial dyes 
(Sumthong and Verpoorte, 2007). After a few failures, Ehrlich came up with his 
606th preparation of an arsphenamine compound in 1910, to be the first chemical 
compound in the world shown to cure a human disease. The compound later named 
as salvarsan, a remedy for syphilis. In 1928, Alexander Fleming discovered an 
antibiotic named penicillin which established into the clinical used in 1940s. 
Antibiotic is described as compounds isolated from one living organism which could 
kill or inhibit the growth of other organisms. All antibiotics are antimicrobials, but 
not all antimicrobials are antibiotics. From his study, Fleming found that a fungus 
from the Penicillium genus, which is Penicillium mold inhibited the growth of 
Staphylococcus aureus bacteria in a petri dish. This finding lead to the discovery that 
microorganism would produce substances that could inhibit the growth of other 
microorganisms. Penicillin is known as a miracle drug in terms of safety and efficacy 
which led to the golden age era of antimicrobial chemotherapy. Realizing the 
importance of antimicrobial therapeutic in medication, a number of subsequent 
antimicrobial discoveries by many other researchers continue to develop. Figure 1.13 
below shows the evolution of penicillin years by years.  
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Figure 1.13 Evolution of penicillin. (Saga and Yamaguchi, 2009) 
There are several synthetic antimicrobial agents that were synthesized based 
on model compounds sulfonamides, quinolones and nitroheterocyclic (nitrofurans, 
metronidazole) compounds (Figure 1.14). Sulfonamide was first discovered in 1935 
by Gerhard Domagk (Yousef et al., 2018). Sulfonamide is a synthetic red dye 
popularly known by its trade name of Prontosil (Yousef et al., 2018). This discovery 
resulted in the effectiveness in treating killer diseases such as meningitis, child bed 
fever and pneumonia. Since then, sulfonamide derivatives are extremely useful and 
synthesized until today (Yousef et al., 2018). On the other hand, quinolones are a 
group of synthetic antibacterial agents derived from nalidixic acid. Nalidixic acid 
was accidently discovered in 1962 as a byproduct from chloroquine, an antimalarial 
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agent. Realizing the importance of quinolone, research and development of its 
derivatives continuously develop. Nitroheterocyclic compounds such as nitrofurans 
and nitroimidazoles played an important role to treat bacterial infection. The 
nitrofurans are derivatives of 5-nitro-2-furaldehyde, that show antimicrobial activity 
only when the nitro group is located at the 5-position. Metronidazole is a 
nitroimidazole structure containing nitro group. The nitro group is reduced to NH2 
after entry to bacterial cell which makes concentration gradient for more 
metronidazole molecules to flow inside the bacteria. The aromatic amine can attack 
DNA and cause bacterial death (Reeves, 2012). 
 
Figure 1.14 Antibacterial sulfonamide’s common core structure 18. Nalidixic acid 
19. Nitroheterocyclic. (nitrofurans and metronidazole) 20.  
Bacteria evolve in some way that reduces or eliminates the effectiveness of 
drugs or chemicals designed to cure infections, thus become resistant. WHO define 
antimicrobial resistance as microorganisms such as bacteria, viruses, fungi and 
parasites develop the ability to defeat the effect of the drugs designed to kill them. 
There are two types of antimicrobial resistance which are intrinsic resistance and 
adaptive or acquired resistance (Molchanova et al., 2017). Intrinsic resistance is the 
ability of the pathogen to resist the antibacterial treatment due to inherent structural 
or functional properties. Meanwhile, the ability of the bacteria to adapt to non-lethal 
conditions by rapidly altering their transcriptomes in response to a stressful 
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environment is best described for adaptive resistance. As such, a continuous 
development of antimicrobial agents is crucial in order to sustain the effectiveness of 
the antimicrobial agents and save lives. However, researchers encounter several 
problems that lead to the slow development of new antimicrobial agent such as time 
consuming and the high cost. On an average, research and development of 
anti-infective drugs takes around 15-20 years, and can cost more than $1000 million 
(Rai et al., 2013). Synthesis of newer antimicrobial compound have to be discovered 
and introduced, not only based on model compounds of sulfonamides, quinolones 
and nitroheterocyclic (nitrofurans, metronidazole) compounds, but variety of 
chemical classes of compounds.  
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1.3 Problem Statement  
There has been vast research conducted on fluorene to explore its potential 
application in biological area including cytotoxicity, antioxidant and antimicrobial 
activities. However, the synthesis and investigation on biological application of 
fluorene derivatives with symmetrical heterocyclic substitution at 2,7-position 
remain quite scanty. This research aims to introduce heterocyclic pyridine, 
benzothiazole and quinoline, respectively with amine and ether as bridging groups to 
the core system of fluorene derivative at symmetrical 2,7-position. In addition, the 
introduction of these heterocyclic are expected to enhance the compounds to be more 
potent cytotoxicity, antioxidant and antimicrobial agents.    
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1.4 Research Objectives 
The overall objectives of this study are shown as follow: 
i. To synthesize a series of new symmetrical 2,7-disubstituted 9,9’-
dihexylfluorene derivatives with amine and ether bridging groups. 
ii. To elucidate the structure of all synthesized compounds using FT-IR and 
NMR as well as their fluorescence properties using UV-Vis and fluorescence 
spectroscopy. 
iii. To investigate the cytotoxicity of all synthesized compounds based on MTT 
assay against HeLa cell line. To study antioxidant activity of all synthesized 
compounds by DPPH scavenging activity assay and antimicrobial activity by 
disc diffusion assay against two Gram-Positive bacteria (Staphylococcus 
aureus and Bacillus subtilis), one Gram-Negative bacteria (Escherichia coli) 
and two yeasts (Candida albicans and Saccharomyces cerevisiae). 
1.5 Scope of the Studies 
The focuses of this study are to synthesize new fluorene derivatives with 
heterocyclic substituents at 2,7-position via amine and ether bridging groups, 
respectively and to investigate their potential anticancer, antioxidant and 
antimicrobial applications. The first and second fluorene derivatives are substituted 
with heterocyclic pyridine and benzothiazole, respectively via amine bridging group. 
The third fluorene derivative is substituted with heterocyclic quinoline with ether 
bridging group. All of the synthesized compounds are characterized by using nuclear 
magnetic resonance (NMR), infrared spectroscopy (IR), UV-Visible 
spectrophotometer and fluorescence spectroscopy. NMR spectroscopy is one of the 
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principle techniques used to obtain structural information by determining the 
chemical shifts in 1H and 13C nuclei of the synthesized compounds based on 1D and 
2D-NMR experiments. IR is used for identifying the main functional groups in the 
compounds. UV-Vis is performed to identify the absorption maxima (λmax) in the UV 
spectra of all synthesized compounds before fluorescence is carried out to confirm 
that the synthesized compounds exhibit fluorescence. 
Potential biological application including cytotoxicity, antioxidant and 
antimicrobial were investigated on all the synthesized compounds. In vitro 
cytotoxicity test is carried out as preliminary data to confirm compounds synthesized 
with potential anticancer properties with IC50 value showing the inhibition 
concentration at which only 50% of the cells are viable. Antioxidant test is conducted 
by DPPH scavenging activity assay to investigate the antioxidant activity of all the 
synthesized compounds. Antimicrobial test is conducted by disc diffusion assay on 
several microorganism including Gram-Positive bacteria, Gram-Negative bacteria 
and yeasts to explore the antimicrobial activity of all synthesized compounds. 
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CHAPTER 2 
EXPERIMENTAL 
2.1 Chemicals 
 The chemicals reagent used for the synthesis of all intermediates and final 
compounds are given in Table 2.1. 
Table 2.1 Chemicals, manufacturer name and the percentage purity (%) 
Chemicals Manufacturer Percentage 
Purity 
(%) 
8-hydroxyquinoline Across Organics, Belgium 99.0 
Potassium Iodide Fisher Scientific, UK >99.0 
Potassium Carbonate Quality Reagent Chemicals, New 
Zealand 
99.0 
2,7-Bis(bromomethyl)-9,9-
dihexyl-9H-fluorene 
Sigma Aldrich, USA 97.0 
Bis(2-pyridylmethyl)amine Tokyo Chemical Industry, Japan >98.0 
2-aminobenzenethiol Tokyo Chemical Industry, Japan >95.0 
Iminodiacetontrile Tokyo Chemical Industry, Japan >98.0 
Quinoline Tokyo Chemical Industry, Japan >98.0 
 
 
 
